miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity
Shashi Kumar Gupta(Central Drug Research Institute), Thomas Thum(Medizinische Hochschule Hannover), Stefan Engelhardt(Heidelberg University), Katrin Streckfuß‐Bömeke(Justus-Liebig-Universität Gießen), Ankita Garg(Shyam Shah Medical College), Petros Avramopoulos(German Centre for Cardiovascular Research), Sándor Bátkai(National Institutes of Health)
Cited by 57
Related Papers
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
MicroRNAs in the Human Heart
|Circulation|2007|888
Progressive hypertrophy and heart failure in β <sub>1</sub> -adrenergic receptor transgenic mice
|Proceedings of the National Academy of Sciences|1999|787
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767